A new MRI scanning technique being investigated in Toronto could one day help physicians identify patients on the path to developing Alzheimer’s disease, and do so at a cost far less than molecular imaging of amyloid deposits, according to an in-depth profile of the project published by theToronto Star.

Read more here.